Microvasculature Recovery by Angiogenesis After Myocardial Infarction

被引:62
作者
Badimon, Lina [2 ,3 ]
Borrell, Maria [1 ,2 ,3 ]
机构
[1] IR Hosp Santa Creu & St Pau, IIB St Pau, Cardiovasc Res Ctr, C St Antoni Maria Claret 167, Barcelona 08025, Spain
[2] UAB, Cardiovasc Res Chair, Barcelona, Spain
[3] Inst Salud Carlos III, CIBER CV, Madrid, Spain
关键词
Angiogenesis; reperfusion therapies; microvascular dysfunction; myocardial infarction; myocardial perfusion; ischemia; FIBROBLAST-GROWTH-FACTOR; HYPOXIA-INDUCIBLE FACTOR; PROGENITOR CELLS; GENE-TRANSFER; PROMOTES ANGIOGENESIS; CORONARY-OCCLUSION; REPERFUSION INJURY; MONOCYTE SUBSETS; SYSTEMIC LEVELS; NO-REFLOW;
D O I
10.2174/1381612824666180629162726
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
Advances in early reperfusion therapies focused on the revascularization of the ischemic tissues, in the last decades, lead to reduced mortality in acute myocardial infarction (MI) patients. However, a large proportion of patients show inadequate myocardial perfusion because of dysfunction of the microcirculation. The high prevalence of microvascular dysfunction after reperfusion therapies and the negative prognostic of this procedure justify the search for therapeutic strategies that aim to restore the microvascular network. It is well known that the size of the initial infarct, the duration of ischemia and the efficiency of reperfusion determine myocardial tissue damage and cardiomyocyte loss after myocardial infarction. Therefore any advancement on the mechanisms that induce the repair process of microvascular dysfunction after reperfused MI is of great interest. Here, we will review the different proteins and cells known to participate in angiogenesis induction post-MI and we will also discuss the potential pharmacological and cellular processes that promote the recovery of microvasculature by angiogenesis stimulation after MI.
引用
收藏
页码:2967 / 2973
页数:7
相关论文
共 79 条
[1]
No-reflow: the next challenge in treatment of ST-elevation acute myocardial infarction [J].
Abbate, Antonio ;
Kontos, Michael C. ;
Biondi-Zoccai, Giuseppe G. L. .
EUROPEAN HEART JOURNAL, 2008, 29 (15) :1795-1797
[2]
Conflict of interest policies and disclosure requirements among European Society of Cardiology National Cardiovascular Journals [J].
Alfonso, Fernando ;
Timmis, Adam ;
Pinto, Fausto J. ;
Ambrosio, Giuseppe ;
Ector, Hugo ;
Kulakowski, Piotr ;
Vardas, Panos ;
Antoniades, L. ;
Ahmad, M. ;
Apetrei, E. ;
Arai, K. ;
Artigou, J.Y. ;
Aschermann, M. ;
Bohm, M. ;
Bolognese, L. ;
Bugiardini, R. ;
Cohen, A ;
Edes, I. ;
Elias, J. ;
Galeano, J. ;
Guarda, E. ;
Haouala, H. ;
Heras, M. ;
Höglund, C. ;
Huber, K. ;
Hulin, I. ;
Ivanusa, M. ;
Krittayaphong, R. ;
Kuo, C.T. ;
Lau, C.P. ;
Lyusov, V.A. ;
Marinskis, G. ;
Masic, I. ;
Marquez, M.F. ;
Felipe, L. ;
Mrochek, A. ;
Oganov, R.G. ;
Raev, D. ;
Rogava, M. ;
Rodevand, O. ;
Sansoy, V. ;
Shimokawa, H. ;
Shumakov, V.A. ;
Tajer, C.D. ;
van der Wall, E. ;
Stefanadis, C. ;
Videbaek, J. ;
Luscher, T.F. .
EUROPEAN HEART JOURNAL, 2012, 33 (05) :587-594
[3]
Tissue factor variants induce monocyte transformation and transdifferentiation into endothelial cell-like cells [J].
Arderiu, G. ;
Espinosa, S. ;
Pena, E. ;
Crespo, J. ;
Aledo, R. ;
Bogdanov, V. Y. ;
Badimon, L. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2017, 15 (08) :1689-1703
[4]
Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb [J].
Arras, M ;
Ito, WD ;
Scholz, D ;
Winkler, B ;
Schaper, J ;
Schaper, W .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (01) :40-50
[5]
Role of PIGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1 [J].
Autiero, M ;
Waltenberger, J ;
Communi, D ;
Kranz, A ;
Moons, L ;
Lambrechts, D ;
Kroll, J ;
Plaisance, S ;
De Mol, M ;
Bono, F ;
Kliche, S ;
Fellbrich, G ;
Ballmer-Hofer, K ;
Maglione, D ;
Mayr-Beyrle, U ;
Dewerchin, M ;
Dombrowski, S ;
Stanimirovic, D ;
Van Hummelen, P ;
Dehio, C ;
Hicklin, DJ ;
Persico, G ;
Herbert, JM ;
Communi, D ;
Shibuya, M ;
Collen, D ;
Conway, EM ;
Carmeliet, P .
NATURE MEDICINE, 2003, 9 (07) :936-943
[6]
EFFECTS OF ACIDIC FIBROBLAST GROWTH-FACTOR ON NORMAL AND ISCHEMIC MYOCARDIUM [J].
BANAI, S ;
JAKLITSCH, MT ;
CASSCELLS, W ;
SHOU, M ;
SHRIVASTAV, S ;
CORREA, R ;
EPSTEIN, SE ;
UNGER, EF .
CIRCULATION RESEARCH, 1991, 69 (01) :76-85
[7]
Chronic Inhibition of Hypoxia-inducible Factor Prolyl 4-hydroxylase Improves Ventricular Performance, Remodeling, and Vascularity After Myocardial Infarction in the Rat [J].
Bao, Weike ;
Qin, Pu ;
Needle, Saul ;
Erickson-Miller, Connie L. ;
Duffy, Kevin J. ;
Ariazi, Jennifer L. ;
Zhao, Shufang ;
Olzinski, Alan R. ;
Behm, David J. ;
Pipes, G. C. Teg ;
Jucker, Beat M. ;
Hu, Erding ;
Lepore, John J. ;
Willette, Robert N. .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2010, 56 (02) :147-155
[8]
BHARGAVA M, 1992, CELL GROWTH DIFFER, V3, P11
[9]
Complement C5a, TGF-beta 1, and MCP-1, in sequence, induce migration of monocytes into ischemic canine myocardium within the first one to five hours after reperfusion [J].
Birdsall, HH ;
Green, DM ;
Trial, J ;
Youker, KA ;
Burns, AR ;
MacKay, CR ;
LaRosa, GJ ;
Hawkins, HK ;
Smith, CW ;
Michael, LH ;
Entman, ML ;
Rossen, RD .
CIRCULATION, 1997, 95 (03) :684-692
[10]
MicroRNA-92a Controls Angiogenesis and Functional Recovery of Ischemic Tissues in Mice [J].
Bonauer, Angelika ;
Carmona, Guillaume ;
Iwasaki, Masayoshi ;
Mione, Marina ;
Koyanagi, Masamichi ;
Fischer, Ariane ;
Burchfield, Jana ;
Fox, Henrik ;
Doebele, Carmen ;
Ohtani, Kisho ;
Chavakis, Emmanouil ;
Potente, Michael ;
Tjwa, Marc ;
Urbich, Carmen ;
Zeiher, Andreas M. ;
Dimmeler, Stefanie .
SCIENCE, 2009, 324 (5935) :1710-1713